The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...

And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile medical practitioners could offer MIT microparticle emulsion as a no-fuss, ...

We’re all mostly human. 8% of your genome comes from viruses. In A Nutshell Scientists captured the first detailed images of ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors and sometimes eliminating them entirely.

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study OverviewRegeneron Pharmaceuticals has launched a new ...

See why TG Therapeutics, Inc. earns a Buy rating, with insights on Briumvi's efficacy and market growth in multiple sclerosis ...

The North Texas Region of the Red Cross operates two fixed donation sites in the area: the Irving Blood and Platelet Donation ...

For the second year in a row, the US has surpassed 25,000 whooping cough cases — another sign of the risks of falling vaccination levels.

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.

Jane Sykes, BVSc, PhD, MPH, MBA, FNAP, summarizes the practical parts of the 2023 ACVIM consensus update on leptospirosis and explains what it means for general practice. She covers the biggest shift ...